Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zippia finds jobs where you're a top candidate and applies on your behalf.
Globus Medical's peak revenue was $2.5B in 2024. The peak quarterly revenue was $657.3M in 2024(q4).
Globus Medical's revenue increased from $331.5m in 2011 to $2.5B currently. That's a 660.04% change in annual revenue.
| Fiscal year / year | Globus Medical revenue |
|---|---|
| 2011 | $331.5M |
| 2012 | $386.0M |
| 2013 | $434.5M |
| 2014 | $474.4M |
| 2015 | $544.8M |
| 2016 | $564.0M |
| 2017 | $636.0M |
| 2018 | $713.0M |
| 2019 | $785.4M |
| 2020 | $789.0M |
| 2021 | $958.1M |
| 2022 | $1.0B |
| 2023 | $1.6B |
| 2024 | $2.5B |
How accurately did Globus Medical's revenue projections match actual performance?
Globus Medical saw the greatest revenue growth in 2021, when revenue increased by 21.43%.
Globus Medical had the lowest revenue growth in 2020, when revenue changed by 0.47%.
| Year | Globus Medical growth |
|---|---|
| 2012 | 16%↑ |
| 2013 | 13%↑ |
| 2014 | 9%↑ |
| 2015 | 15%↑ |
| 2016 | 4%↑ |
| 2017 | 13%↑ |
| 2018 | 12%↑ |
| 2019 | 10%↑ |
| 2020 | 0%↑ |
| 2021 | 21%↑ |
| 2022 | 7%↑ |
| 2023 | 53%↑ |
| 2024 | 61%↑ |
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2012 | - | $96.0M | $94.8M | $100.5M |
| 2013 | $105.0M | $107.0M | $107.2M | $115.2M |
| 2014 | $114.2M | $113.6M | $117.8M | $128.8M |
| 2015 | $131.6M | $133.6M | $137.0M | $142.6M |
| 2016 | $139.3M | $137.5M | $135.7M | $151.6M |
| 2017 | $155.8M | $152.4M | $151.7M | $176.0M |
| 2018 | $174.4M | $173.4M | $169.2M | $195.9M |
| 2019 | $182.9M | $194.5M | $196.2M | $211.7M |
| 2020 | $190.6M | $148.9M | $216.1M | $233.4M |
| 2021 | $227.3M | $251.0M | $229.7M | $250.0M |
| 2022 | $230.5M | $263.6M | $254.1M | $274.5M |
| 2023 | $276.7M | $291.6M | $383.6M | $616.5M |
| 2024 | $606.7M | $629.7M | $625.7M | $657.3M |
Do you work at Globus Medical?
Is Globus Medical transparent about its revenue structure?
| CEO | Daniel T. Scavilla |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 1,800 |
| Date Founded | 2003 |
| Headquarters | Audubon, Pennsylvania |
| Number of Locations | 4 |
| Revenue | $2.5B |
| Net Income | $190,169,000 |
| Gross Proft | $1.5B (2024) |
| EBITDA | $244.3M (2024) |
| PE Ratio | 28.65 |
| Tax Rate | 0.1% |
| Market Capitalization | $3.0B |
| Total Assets | $2,076,126,000 |
| Ticker | GMED |
Globus Medical received early financing of $2.1M on 2003-10-23.
| Series | Round size | Date |
|---|---|---|
| Series A | $2M | 10/2003 |
| Series B | $3M | 06/2004 |
| Series C | $4.0M | 06/2005 |
| Series D | $9.5M | 02/2007 |
| Series E | $110M | 08/2007 |
| Investors | Security type |
|---|---|
| KM Medical Software | Series A |
| The Goldman Sachs Group, Inc. | Series E |
| CLARUS VENTURES LLC | Series E |
| AIG Investments | Series E |
Globus Medical's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.
Globus Medical's smallest competitor is Invuity with revenue of $39.6M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Stryker | $69,470 | $22.6B | 43,000 | 2,018 |
| Abiomed | $99,022 | $1.0B | 1,536 | - |
| Intersect ENT | $67,446 | $106.7M | 393 | - |
| Ethicon | $62,256 | $4.9B | 11,000 | - |
| CoolSculpting | $73,648 | $342.1M | 686 | - |
| Invuity | $63,343 | $39.6M | 161 | - |
| Danaher | $65,463 | $23.9B | 80,000 | 1,731 |
| Sanofi Genzyme | $84,495 | $4.6B | 12,000 | - |
| MAKO Surgical | $90,432 | $102.7M | 436 | - |
| Johnson & Johnson | $76,686 | $88.8B | 134,500 | 1,719 |
Zippia gives an in-depth look into the details of Globus Medical, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Globus Medical. The employee data is based on information from people who have self-reported their past or current employments at Globus Medical. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Globus Medical. The data presented on this page does not represent the view of Globus Medical and its employees or that of Zippia.
Globus Medical may also be known as or be related to Globus Medical, Globus Medical Inc, Globus Medical Inc. and Globus Medical, Inc.